confirmed that the intraperitoneal administration of a specific inhibitor of TRPV1 channels can lead to hippocampal astrocyte overactivation, prevent neuronal dysfunction and maintain structural synaptic integrity to ameliorate spatial working memory in Alzheimer's disease.34 This evidence concerns the gene TRPV1 and Alzheimer disease.